Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP253160.RAVhbyaZkk9VDeh7RqdxiQzaPOFMLvwFEdr2JamSX-yZw130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP253160.RAVhbyaZkk9VDeh7RqdxiQzaPOFMLvwFEdr2JamSX-yZw130_assertion type Assertion NP253160.RAVhbyaZkk9VDeh7RqdxiQzaPOFMLvwFEdr2JamSX-yZw130_head.
- NP253160.RAVhbyaZkk9VDeh7RqdxiQzaPOFMLvwFEdr2JamSX-yZw130_assertion description "[Positivity rates for any oncogenic HPV infection and for HPV16 and/or 18 within confirmed CIN2/3-AIS were 95% (95%CI: 92-97%) and 60% (54-65%) respectively; in all women with ASC-H/HSIL+/AGC/AIS cytology it was 87% (84-89%) and 53% (49-57%), respectively.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP253160.RAVhbyaZkk9VDeh7RqdxiQzaPOFMLvwFEdr2JamSX-yZw130_provenance.
- NP253160.RAVhbyaZkk9VDeh7RqdxiQzaPOFMLvwFEdr2JamSX-yZw130_assertion evidence source_evidence_literature NP253160.RAVhbyaZkk9VDeh7RqdxiQzaPOFMLvwFEdr2JamSX-yZw130_provenance.
- NP253160.RAVhbyaZkk9VDeh7RqdxiQzaPOFMLvwFEdr2JamSX-yZw130_assertion SIO_000772 23452957 NP253160.RAVhbyaZkk9VDeh7RqdxiQzaPOFMLvwFEdr2JamSX-yZw130_provenance.
- NP253160.RAVhbyaZkk9VDeh7RqdxiQzaPOFMLvwFEdr2JamSX-yZw130_assertion wasDerivedFrom befree-20150227 NP253160.RAVhbyaZkk9VDeh7RqdxiQzaPOFMLvwFEdr2JamSX-yZw130_provenance.
- NP253160.RAVhbyaZkk9VDeh7RqdxiQzaPOFMLvwFEdr2JamSX-yZw130_assertion wasGeneratedBy ECO_0000203 NP253160.RAVhbyaZkk9VDeh7RqdxiQzaPOFMLvwFEdr2JamSX-yZw130_provenance.